Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease ; volume:21 ; number:1 ; day:16 ; month:1 ; year:2020 ; pages:1-9 ; date:12.2020
BMC nephrology ; 21, Heft 1 (16.1.2020), 1-9, 12.2020
- Urheber
-
Iliescu, Elena Laura
Mercan-Stanciu, Adriana
Toma, Letitia
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12882-020-1687-1
- URN
-
urn:nbn:de:101:1-2020042008511676705378
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Iliescu, Elena Laura
- Mercan-Stanciu, Adriana
- Toma, Letitia
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study
A Cost-Effectiveness Analysis of Glecaprevir/Pibrentasvir Versus Existing Direct-Acting Antivirals to Treat Chronic Hepatitis C in Japan
Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden
Short-term changes observed in multiparametric liver MRI following therapy with direct-acting antivirals in chronic hepatitis C virus patients
Effect of direct-acting antivirals on corrected QT interval and cardiac functions in patients with chronic hepatitis C virus infection
Real-world treatment outcome of direct-acting antivirals and patient survival rates in chronic hepatitis C virus infection in Eritrea
Direct-acting antivirals and visceral leishmaniasis: a case report
The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patients
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study
A Cost-Effectiveness Analysis of Glecaprevir/Pibrentasvir Versus Existing Direct-Acting Antivirals to Treat Chronic Hepatitis C in Japan
Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden
Short-term changes observed in multiparametric liver MRI following therapy with direct-acting antivirals in chronic hepatitis C virus patients
Effect of direct-acting antivirals on corrected QT interval and cardiac functions in patients with chronic hepatitis C virus infection
Real-world treatment outcome of direct-acting antivirals and patient survival rates in chronic hepatitis C virus infection in Eritrea
Direct-acting antivirals and visceral leishmaniasis: a case report
The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patients
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study
A Cost-Effectiveness Analysis of Glecaprevir/Pibrentasvir Versus Existing Direct-Acting Antivirals to Treat Chronic Hepatitis C in Japan
Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden
Short-term changes observed in multiparametric liver MRI following therapy with direct-acting antivirals in chronic hepatitis C virus patients
Effect of direct-acting antivirals on corrected QT interval and cardiac functions in patients with chronic hepatitis C virus infection
Real-world treatment outcome of direct-acting antivirals and patient survival rates in chronic hepatitis C virus infection in Eritrea
Direct-acting antivirals and visceral leishmaniasis: a case report